The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

54 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of [1,2,3]Triazolo[4,5-EBI
Key Laboratory Of Technology Of Drug Preparation (Zhengzhou University)
Activation of lysine-specific demethylase 1 inhibitor peptide by redox-controlled cleavage of a traceless linker.EBI
Nagoya City University
Impact of Binding Site Comparisons on Medicinal Chemistry and Rational Molecular Design.EBI
Tu Dortmund University
Efficient synthesis of new antiproliferative steroidal hybrids using the molecular hybridization approach.EBI
Zhengzhou University
Recent Progress in Histone Demethylase Inhibitors.EBI
University Of Oxford
Cyclopropanamine Compounds and Use Thereof.EBI
Temple University
Identification of SNAIL1 Peptide-Based Irreversible Lysine-Specific Demethylase 1-Selective Inactivators.EBI
Kyoto Prefectural University Of Medicine
Evaluation of phenylcyclopropylamine compounds by enzymatic assay of lysine-specific demethylase 2 in the presence of NPAC peptide.EBI
Waseda University
3-(Piperidin-4-ylmethoxy)pyridine Containing Compounds Are Potent Inhibitors of Lysine Specific Demethylase 1.EBI
Baylor College Of Medicine
Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators.EBI
Shandong University
Pure Diastereomers of a Tranylcypromine-Based LSD1 Inhibitor: Enzyme Selectivity and In-Cell Studies.EBI
Sapienza University Of Rome
Pure enantiomers of benzoylamino-tranylcypromine: LSD1 inhibition, gene modulation in human leukemia cells and effects on clonogenic potential of murine promyelocytic blasts.EBI
Sapienza University Of Rome
Design, synthesis, and structure-activity relationship of novel LSD1 inhibitors based on pyrimidine-thiourea hybrids as potent, orally active antitumor agents.EBI
Zhengzhou University
Histone H3 peptide based LSD1-selective inhibitors.EBI
Waseda University
Structure-activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures.EBI
John Hopkins University
Synthesis, biological activity and mechanistic insights of 1-substituted cyclopropylamine derivatives: a novel class of irreversible inhibitors of histone demethylase KDM1A.EBI
European Institute Of Oncology
Synthesis and evaluation of novel cyclic Peptide inhibitors of lysine-specific demethylase 1.EBI
Medical University Of South Carolina
High-throughput virtual screening identifies novel N'-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors.EBI
University Of Utah
Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration.EBI
Zhengzhou University
Nonpeptidic propargylamines as inhibitors of lysine specific demethylase 1 (LSD1) with cellular activity.EBI
University Of Freiburg
Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1.EBI
Wayne State University
Oncoepigenomics: making histone lysine methylation count.EBI
TBA
(Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators.EBI
Wayne State University
Lysine demethylases inhibitors.EBI
Kyoto Prefectural University Of Medicine
Inhibitors of histone demethylases.EBI
University Of Copenhagen
Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors.EBI
University Of Southampton
Synthesis and biological activity of optically active NCL-1, a lysine-specific demethylase 1 selective inhibitor.EBI
Nagoya City University
Synthesis and biological evaluation of novel N, N'-disubstituted urea and thiourea derivatives as potential anti-melanoma agents.BDB
Nanjing University
Heme Proximal Hydrogen Bonding between His170 and Asp132 Plays an Essential Role in the Heme Degradation Reaction of HutZ from Vibrio cholerae.BDB
Hokkaido University
Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain.BDB
Oncology Innovative Medicines Unit
Novel N-substituted 2-phenyl-1-sulfonylamino-cyclopropane carboxylates as selective ADAMTS-5 (Aggrecanase-2) inhibitors.BDB
Japan Tobacco
A Structure-Activity Relationship Study and Combinatorial Synthetic Approach of C-Terminal Modified Bifunctional Peptides That Are delta/mu Opioid Receptor Agonists and Neurokinin 1 Receptor Antagonists.BDB
University Of Arizona Tucson
Synthesis and SAR of arylaminoethyl amides as noncovalent inhibitors of cathepsin S: P3 cyclic ethers.BDB
Gnf
Thyroid receptor ligands. Part 7: Indirect antagonists of the thyroid hormone receptor with improved affinity.BDB
Karo Bio
Synthesis and aminoacyl-tRNA synthetase inhibitory activity of aspartyl adenylate analogs.BDB
Crefsip
Acylguanidines as small-molecule beta-secretase inhibitors.BDB
Wyeth Research
Structure-based design and synthesis of macroheterocyclic peptidomimetic inhibitors of the aspartic protease beta-site amyloid precursor protein cleaving enzyme (BACE).BDB
Universite De Montreal At Succursale Centre-Ville
Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation.BDB
Astex
Time-dependent inactivation of aromatase by 6-alkylandrosta-1,4-diene-3,17-diones. Effects of length and configuration of 6-alkyl group.BDB
Tohoku College Of Pharmacy
HIV-1 protease inhibitors with picomolar potency against PI-resistant HIV-1 by modification of the P1' substituent.BDB
Merck Research Laboratories
6-aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).BDB
Glaxosmithkline
Structure-based design of 2-arylamino-4-cyclohexylmethyl-5-nitroso-6-aminopyrimidine inhibitors of cyclin-dependent kinases 1 and 2.BDB
University Of Newcastle
Discovery of 5-[5-fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase.BDB
Sugen
3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamines and related 2-urea derivatives are potent and selective inhibitors of the FGF receptor-1 tyrosine kinase.BDB
University Of Auckland
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors.BDB
Hebrew University Of Jerusalem
Direct Interaction of Chivosazole F with Actin Elicits Cell Responses Similar to Latrunculin A but Distinct from Chondramide.BDB
Novartis Pharma
Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1.BDB
University Of Otago
Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs.BDB
Eli Lilly